Search Results - "McConnell, Joseph P"

Prevalence of Elevated Lp(a) Mass Levels and Patient Thresholds in 532 359 Patients in the United States by Varvel, Steve, McConnell, Joseph P, Tsimikas, Sotirios

“…OBJECTIVE—Elevated lipoprotein(a) [Lp(a)] is a causal, independent risk factor for cardiovascular disease and aortic stenosis. We aimed to define the…”
Get full text

Endurance Exercise as a Countermeasure for Aging by LANZA, Ian R, SHORT, Daniel K, SHORT, Kevin R, RAGHAVAKAIMAL, Sreekumar, BASU, Rita, JOYNER, Michael J, MCCONNELL, Joseph P, SREEKUMARAN NAIR, K

“…Endurance Exercise as a Countermeasure for Aging Ian R. Lanza , Daniel K. Short , Kevin R. Short , Sreekumar Raghavakaimal , Rita Basu , Michael J. Joyner ,…”
Get full text

Chylous Ascites: Reassessment of Diagnostic Criteria in Patients With Portal Hypertension by Matchett, Caroline L., Rattan, Puru, McConnell, Joseph P., Donato, Leslie J., Simonetto, Douglas A., Kamath, Patrick S.

“…The triglyceride (TG) threshold for diagnosis of chylous ascites in patients with portal hypertension remains uncertain. Retrospective analysis of lipoprotein…”
Get full text

Low-Density Lipoprotein Cholesterol Corrected for Lipoprotein(a) Cholesterol, Risk Thresholds, and Cardiovascular Events by Willeit, Peter, Yeang, Calvin, Moriarty, Patrick M, Tschiderer, Lena, Varvel, Stephen A, McConnell, Joseph P, Tsimikas, Sotirios

“…Background Conventional "low-density lipoprotein cholesterol (LDL-C)" assays measure cholesterol content in both low-density lipoprotein and lipoprotein(a)…”
Get full text

Oxidized Phospholipids, Lp(a) Lipoprotein, and Coronary Artery Disease by Tsimikas, Sotirios, Brilakis, Emmanouil S, Miller, Elizabeth R, McConnell, Joseph P, Lennon, Ryan J, Kornman, Kenneth S, Witztum, Joseph L, Berger, Peter B

“…Lp(a) lipoprotein is believed to be involved in the pathogenesis of coronary artery disease. This study provides evidence that its atherogenicity is related to…”
Get full text

Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events by Tsimikas, Sotirios, Brilakis, Emmanouil S., Lennon, Ryan J., Miller, Elizabeth R., Witztum, Joseph L., McConnell, Joseph P., Kornman, Kenneth S., Berger, Peter B.

“…The relationship between autoantibodies to oxidized low density lipoprotein (OxLDL) and coronary artery disease (CAD) remains controversial. IgM and IgG OxLDL…”
Get full text

Comparative effects of an acute dose of fish oil on omega-3 fatty acid levels in red blood cells versus plasma: Implications for clinical utility by Harris, William S., PhD, Varvel, Stephen A., PhD, Pottala, James V., PhD, Warnick, G. Russell, MS, MBA, McConnell, Joseph P., PhD

“…Background Omega-3 fatty acid (n-3 FA) biostatus can be estimated with red blood cell (RBC) membranes or plasma. The matrix that exhibits the lower…”
Get full text

Consensus Panel Recommendation for Incorporating Lipoprotein-Associated Phospholipase A2 Testing into Cardiovascular Disease Risk Assessment Guidelines by Davidson, Michael H., MD, Corson, Marshall A., MD, Alberts, Mark J., MD, Anderson, Jeffrey L., MD, Gorelick, Philip B., MD, Jones, Peter H., MD, Lerman, Amir, MD, McConnell, Joseph P., PhD, Weintraub, Howard S., MD

“…A consensus panel was formed to review the rapidly emerging literature on the vascular-specific inflammatory marker lipoprotein-associated phospholipase A2…”
Get full text

Lipoprotein-Associated Phospholipase A2 : A Risk Marker or a Risk Factor? by Lerman, Amir, MD, McConnell, Joseph P., PhD

“…Multiple cardiovascular biomarkers are associated with increased cardiovascular disease (CVD) risk. Lipoprotein-associated phospholipase A2 (Lp-PLA2 ) appears…”
Get full text

Biomarkers of cholesterol homeostasis in a clinical laboratory database sample comprising 667,718 patients by Dayspring, Thomas D., MD, FACP, FNLA, Varvel, Stephen A., PhD, Ghaedi, Leila, PhD, Thiselton, Dawn L., PhD, Bruton, James, MS, McConnell, Joseph P., PhD, DABCC

“…Background Circulating noncholesterol sterols/stanols (NCS) are used in clinical lipidology as surrogate measures of cholesterol synthesis and absorption,…”
Get full text

Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve by RAJAMANNAN, Nalini M, SUBRAMANIAM, Malayannan, SPRINGETT, Margaret, SEBO, Thomas C, NIEKRASZ, Marek, MCCONNELL, Joseph P, SINGH, Ravinder J, STONE, Neil J, BONOW, Robert O, SPELSBERG, Thomas C

“…Despite the common occurrence of aortic stenosis, the cellular causes of the disorder are unknown, in part because of the absence of experimental models. We…”
Get full text

Lipoprotein(a) mass: A massively misunderstood metric by McConnell, Joseph P., PhD, Guadagno, Philip A., MS, Dayspring, Thomas D., MD, Hoefner, Daniel M., PhD, Thiselton, Dawn L., PhD, Warnick, G. Russell, MS, Harris, William S., PhD

“…Abstract The importance of lipoprotein (a)—Lp(a)—as a cardiovascular (CV) risk marker has been underscored by recent findings that CV risk is directly related…”
Get full text

Myocardial Tissue Remodeling in Adolescent Obesity by Shah, Ravi V., Abbasi, Siddique A., Neilan, Tomas G., Hulten, Edward, Coelho‐Filho, Otavio, Hoppin, Alison, Levitsky, Lynne, Ferranti, Sarah, Rhodes, Erinn T., Traum, Avram, Goodman, Elizabeth, Feng, Henry, Heydari, Bobak, Harris, William S., Hoefner, Daniel M., McConnell, Joseph P., Seethamraju, Ravi, Rickers, Carsten, Kwong, Raymond Y., Jerosch‐Herold, Michael

“…Background Childhood obesity is a significant risk factor for cardiovascular disease in adulthood. Although ventricular remodeling has been reported in obese…”
Get full text

Discordance between apolipoprotein B and low-density lipoprotein particle number is associated with insulin resistance in clinical practice by Varvel, Stephen A., PhD, Dayspring, Thomas D., MD, Edmonds, Yvette, PhD, Thiselton, Dawn L., PhD, Ghaedi, Leila, PhD, Voros, Szilard, MD, McConnell, Joseph P., PhD, Sasinowski, Maciek, MD, PhD, Dall, Tara, MD, Warnick, G. Russell, MSc, MBA

“…Background Discordance between measures of atherogenic lipoprotein particle number (apolipoprotein B [ApoB] and low-density lipoprotein [LDL] particle number…”
Get full text

Effect of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial Infarction: The OMEGA-REMODEL Randomized Clinical Trial by Heydari, Bobak, Abdullah, Shuaib, Pottala, James V, Shah, Ravi, Abbasi, Siddique, Mandry, Damien, Francis, Sanjeev A, Lumish, Heidi, Ghoshhajra, Brian B, Hoffmann, Udo, Appelbaum, Evan, Feng, Jiazhuo H, Blankstein, Ron, Steigner, Michael, McConnell, Joseph P, Harris, William, Antman, Elliott M, Jerosch-Herold, Michael, Kwong, Raymond Y

“…BACKGROUND:Omega-3 fatty acids from fish oil have been associated with beneficial cardiovascular effects, but their role in modifying cardiac structures and…”
Get full text

Lipoprotein(a) Mass Levels Increase Significantly According to APOE Genotype: An Analysis of 431 239 Patients by Moriarty, Patrick M, Varvel, Stephen A, Gordts, Philip L.S.M, McConnell, Joseph P, Tsimikas, Sotirios

“…OBJECTIVE—Lipoprotein(a) [Lp(a)] levels are genetically determined by hepatocyte apolipoprotein(a) synthesis, but catabolic pathways also influence circulating…”
Get full text

Comparison of cardiometabolic risk biomarkers from a national clinical laboratory with the US adult population by Wolin, Elliott, PhD, White, Justin, MS, Pottala, James V., PhD, Sasinowski, Maciek, PhD, MD, Dall, Tara, MD, Dayspring, Thomas D., MD, McConnell, Joseph P., PhD, Hoefner, Daniel M., PhD, Varvel, Stephen A., PhD, Thiselton, Dawn L., PhD, Warnick, G. Russell, MS, Harris, William S., PhD

“…Background Clinical laboratory patient databases are an untapped source of valuable diagnostic and prognostic information. However, the lack of associated…”
Get full text

Race is a key variable in assigning lipoprotein(a) cutoff values for coronary heart disease risk assessment: the Multi-Ethnic Study of Atherosclerosis by Guan, Weihua, Cao, Jing, Steffen, Brian T, Post, Wendy S, Stein, James H, Tattersall, Mathew C, Kaufman, Joel D, McConnell, Joseph P, Hoefner, Daniel M, Warnick, Russell, Tsai, Michael Y

“…We aimed to examine associations of lipoprotein(a) (Lp(a)) concentrations with coronary heart disease (CHD) and determine whether current Lp(a) clinical…”
Get full text

Systemic Inflammation and Metabolic Syndrome in Cardiac Allograft Vasculopathy by Raichlin, Eugenia R., MD, McConnell, Joseph P., PhD, Lerman, Amir, MD, Kremers, Walter K., PhD, Edwards, Brooks S., MD, Kushwaha, Sudhir S., MD, Clavell, Alfredo L., MD, Rodeheffer, Richard J., MD, Frantz, Robert P., MD

“…Background Metabolic syndrome and elevation of inflammatory markers is common in transplant recipients. We investigated the role of insulin resistance and…”
Get full text

Lipoprotein(a) Levels Are Associated With Subclinical Calcific Aortic Valve Disease in White and Black Individuals: The Multi-Ethnic Study of Atherosclerosis by Cao, Jing, Steffen, Brian T, Budoff, Matthew, Post, Wendy S, Thanassoulis, George, Kestenbaum, Bryan, McConnell, Joseph P, Warnick, Russell, Guan, Weihua, Tsai, Michael Y

“…OBJECTIVE—Lipoprotein(a) [Lp(a)] is a risk factor for calcific aortic valve disease (CAVD) but has not been evaluated across multiple races/ethnicities. This…”
Get full text